1. Home
  2. GVA vs FOLD Comparison

GVA vs FOLD Comparison

Compare GVA & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Construction Incorporated

GVA

Granite Construction Incorporated

HOLD

Current Price

$123.00

Market Cap

5.2B

Sector

Industrials

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.38

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GVA
FOLD
Founded
1922
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.5B
IPO Year
1995
2006

Fundamental Metrics

Financial Performance
Metric
GVA
FOLD
Price
$123.00
$14.38
Analyst Decision
Hold
Buy
Analyst Count
3
9
Target Price
$118.33
$27.25
AVG Volume (30 Days)
588.3K
2.7M
Earning Date
05-14-2026
05-12-2026
Dividend Yield
0.43%
N/A
EPS Growth
47.33
50.00
EPS
3.86
N/A
Revenue
$1,762,965,000.00
N/A
Revenue This Year
$13.46
$20.50
Revenue Next Year
$6.83
$18.59
P/E Ratio
$31.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$69.08
$5.66
52 Week High
$137.24
$14.39

Technical Indicators

Market Signals
Indicator
GVA
FOLD
Relative Strength Index (RSI) 40.30 69.55
Support Level $116.73 $14.21
Resistance Level $124.99 N/A
Average True Range (ATR) 3.37 0.02
MACD -1.56 -0.02
Stochastic Oscillator 13.12 78.57

Price Performance

Historical Comparison
GVA
FOLD

About GVA Granite Construction Incorporated

Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: